153 related articles for article (PubMed ID: 27313493)
21. Targeting Focal Adhesion Kinase and Resistance to mTOR Inhibition in Pancreatic Neuroendocrine Tumors.
François RA; Maeng K; Nawab A; Kaye FJ; Hochwald SN; Zajac-Kaye M
J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 25971297
[TBL] [Abstract][Full Text] [Related]
22. Combined inhibition of glycolysis and AMPK induces synergistic breast cancer cell killing.
Wu Y; Sarkissyan M; Mcghee E; Lee S; Vadgama JV
Breast Cancer Res Treat; 2015 Jun; 151(3):529-39. PubMed ID: 25975952
[TBL] [Abstract][Full Text] [Related]
23. In self-defence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death.
Azoulay-Zohar H; Israelson A; Abu-Hamad S; Shoshan-Barmatz V
Biochem J; 2004 Jan; 377(Pt 2):347-55. PubMed ID: 14561215
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effects of Zengshengping fractions on DMBA-induced buccal pouch carcinogenesis in hamsters.
Guan XB; Sun Z; Chen XX; Wu HR; Zhang XY
Chin Med J (Engl); 2012 Jan; 125(2):332-7. PubMed ID: 22340569
[TBL] [Abstract][Full Text] [Related]
25. Targeting VDAC-bound hexokinase II: a promising approach for concomitant anti-cancer therapy.
Krasnov GS; Dmitriev AA; Lakunina VA; Kirpiy AA; Kudryavtseva AV
Expert Opin Ther Targets; 2013 Oct; 17(10):1221-33. PubMed ID: 23984984
[TBL] [Abstract][Full Text] [Related]
26. Effects of curcumin on cancer cell mitochondrial function and potential monitoring with ¹⁸F-FDG uptake.
Jung KH; Lee JH; Park JW; Moon SH; Cho YS; Choe YS; Lee KH
Oncol Rep; 2016 Feb; 35(2):861-8. PubMed ID: 26718769
[TBL] [Abstract][Full Text] [Related]
27. Anticancer activity of salicin and fenofibrate.
Sabaa M; ELFayoumi HM; Elshazly S; Youns M; Barakat W
Naunyn Schmiedebergs Arch Pharmacol; 2017 Oct; 390(10):1061-1071. PubMed ID: 28733879
[TBL] [Abstract][Full Text] [Related]
28. Oroxylin A sensitizes non-small cell lung cancer cells to anoikis via glucose-deprivation-like mechanisms: c-Src and hexokinase II.
Wei L; Dai Q; Zhou Y; Zou M; Li Z; Lu N; Guo Q
Biochim Biophys Acta; 2013 Jun; 1830(6):3835-45. PubMed ID: 23500080
[TBL] [Abstract][Full Text] [Related]
29. The dietary phytochemical 3,3'-diindolylmethane induces G2/M arrest and apoptosis in oral squamous cell carcinoma by modulating Akt-NF-κB, MAPK, and p53 signaling.
Weng JR; Bai LY; Chiu CF; Wang YC; Tsai MH
Chem Biol Interact; 2012 Feb; 195(3):224-30. PubMed ID: 22290291
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic effects of antibiotic drug mefloquine against cervical cancer through impairing mitochondrial function and inhibiting mTOR pathway.
Li H; Jiao S; Li X; Banu H; Hamal S; Wang X
Can J Physiol Pharmacol; 2017 Jan; 95(1):43-50. PubMed ID: 27831748
[TBL] [Abstract][Full Text] [Related]
31. Anticancer Effects of γ-Tocotrienol Are Associated with a Suppression in Aerobic Glycolysis.
Parajuli P; Tiwari RV; Sylvester PW
Biol Pharm Bull; 2015; 38(9):1352-60. PubMed ID: 26328490
[TBL] [Abstract][Full Text] [Related]
32. The miR-873/NDFIP1 axis promotes hepatocellular carcinoma growth and metastasis through the AKT/mTOR-mediated Warburg effect.
Zhang Y; Zhang C; Zhao Q; Wei W; Dong Z; Shao L; Li J; Wu W; Zhang H; Huang H; Liu F; Jin S
Am J Cancer Res; 2019; 9(5):927-944. PubMed ID: 31218102
[TBL] [Abstract][Full Text] [Related]
33. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
[TBL] [Abstract][Full Text] [Related]
34. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
[TBL] [Abstract][Full Text] [Related]
35. Key regions of VDAC1 functioning in apoptosis induction and regulation by hexokinase.
Shoshan-Barmatz V; Zakar M; Rosenthal K; Abu-Hamad S
Biochim Biophys Acta; 2009 May; 1787(5):421-30. PubMed ID: 19094960
[TBL] [Abstract][Full Text] [Related]
36. Peroxisome proliferator-activated receptor-alpha selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice.
Srivastava RA; Jahagirdar R; Azhar S; Sharma S; Bisgaier CL
Mol Cell Biochem; 2006 Apr; 285(1-2):35-50. PubMed ID: 16477380
[TBL] [Abstract][Full Text] [Related]
37. VDAC electronics: 2. A new, anaerobic mechanism of generation of the membrane potentials in mitochondria.
Lemeshko VV
Biochim Biophys Acta; 2014 Jul; 1838(7):1801-8. PubMed ID: 24565793
[TBL] [Abstract][Full Text] [Related]
38. Combined cetuximab and genistein treatment shows additive anti-cancer effect on oral squamous cell carcinoma.
Park SJ; Kim MJ; Kim YK; Kim SM; Park JY; Myoung H
Cancer Lett; 2010 Jun; 292(1):54-63. PubMed ID: 19959278
[TBL] [Abstract][Full Text] [Related]
39. Unmetabolized fenofibrate, but not fenofibric acid, activates AMPK and inhibits the expression of phosphoenolpyruvate carboxykinase in hepatocytes.
Murakami R; Murakami H; Kataoka H; Cheng XW; Takahashi R; Numaguchi Y; Murohara T; Okumura K
Life Sci; 2010 Oct; 87(15-16):495-500. PubMed ID: 20849861
[TBL] [Abstract][Full Text] [Related]
40. Bortezomib-enhanced radiosensitization through the suppression of radiation-induced nuclear factor-κB activity in human oral cancer cells.
Tamatani T; Takamaru N; Hara K; Kinouchi M; Kuribayashi N; Ohe G; Uchida D; Fujisawa K; Nagai H; Miyamoto Y
Int J Oncol; 2013 Mar; 42(3):935-44. PubMed ID: 23340716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
